X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1632) 1632
Publication (129) 129
Book Review (19) 19
Newsletter (11) 11
Magazine Article (3) 3
Book / eBook (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1493) 1493
ethanolamines - therapeutic use (1040) 1040
male (999) 999
female (975) 975
middle aged (735) 735
adult (734) 734
index medicus (700) 700
ethanolamines - administration & dosage (532) 532
ethanolamines - adverse effects (518) 518
aged (504) 504
formoterol fumarate (454) 454
treatment outcome (408) 408
asthma - drug therapy (398) 398
drug combinations (392) 392
adolescent (341) 341
double-blind method (339) 339
drug therapy, combination (280) 280
pharmacology & pharmacy (276) 276
child (270) 270
bronchodilator agents - therapeutic use (263) 263
formoterol (256) 256
animals (255) 255
asthma (249) 249
administration, inhalation (247) 247
hypertension - drug therapy (246) 246
bronchodilator agents - administration & dosage (228) 228
drug therapy (225) 225
respiratory system (218) 218
malaria (209) 209
ethanolamines - pharmacology (205) 205
fluorenes - therapeutic use (196) 196
child, preschool (195) 195
antimalarials - therapeutic use (192) 192
clinical trials as topic (186) 186
artemisinins - therapeutic use (184) 184
malaria, falciparum - drug therapy (182) 182
blood pressure - drug effects (181) 181
nebivolol (181) 181
research (180) 180
efficacy (176) 176
dose-response relationship, drug (168) 168
bronchodilator agents - adverse effects (163) 163
time factors (161) 161
salmeterol (160) 160
albuterol - therapeutic use (158) 158
young adult (157) 157
adrenergic beta-agonists - therapeutic use (156) 156
benzopyrans - therapeutic use (150) 150
safety (150) 150
care and treatment (146) 146
infant (142) 142
asthma - physiopathology (138) 138
pulmonary disease, chronic obstructive - drug therapy (137) 137
budesonide (136) 136
infectious diseases (135) 135
children (134) 134
labetalol - therapeutic use (134) 134
budesonide - therapeutic use (132) 132
heart rate - drug effects (124) 124
tropical medicine (123) 123
aged, 80 and over (122) 122
antimalarials - adverse effects (120) 120
analysis (119) 119
adrenergic beta-antagonists - therapeutic use (118) 118
ethanolamines (117) 117
albuterol - analogs & derivatives (115) 115
fluorenes - adverse effects (115) 115
artemisinins - adverse effects (114) 114
budesonide - administration & dosage (114) 114
labetalol - adverse effects (112) 112
forced expiratory volume (110) 110
health aspects (110) 110
parasitology (110) 110
cardiac & cardiovascular systems (109) 109
dosage and administration (109) 109
adrenergic beta-agonists - adverse effects (106) 106
parasitic diseases (106) 106
fluorenes - administration & dosage (105) 105
antimalarials - administration & dosage (104) 104
cross-over studies (101) 101
nebulizers and vaporizers (101) 101
artemether-lumefantrine (100) 100
artemisinins - administration & dosage (99) 99
drug administration schedule (98) 98
medicine, general & internal (98) 98
randomized controlled trials as topic (98) 98
ethanolamines - pharmacokinetics (96) 96
hypertension (95) 95
clinical trials (94) 94
adrenergic beta-agonists - administration & dosage (92) 92
salmeterol xinafoate (91) 91
albuterol - administration & dosage (90) 90
therapy (90) 90
plasmodium falciparum (89) 89
prospective studies (88) 88
forced expiratory volume - drug effects (87) 87
albuterol - adverse effects (85) 85
antihypertensive agents - therapeutic use (85) 85
salbutamol (84) 84
anti-asthmatic agents - therapeutic use (81) 81
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1534) 1534
German (50) 50
French (17) 17
Russian (10) 10
Italian (7) 7
Polish (5) 5
Spanish (5) 5
Bulgarian (3) 3
Chinese (3) 3
Japanese (3) 3
Portuguese (2) 2
Romanian (2) 2
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Evidence‐Based Child Health: A Cochrane Review Journal, ISSN 1557-6272, 09/2010, Volume 5, Issue 3, pp. 1456 - 1542
Journal Article
Thorax, ISSN 0040-6376, 02/2014, Volume 69, Issue 2, pp. 130 - 136
Background In mild asthma exercise-induced bronchoconstriction (EIB) is usually treated with inhaled short-acting beta(2) agonists (SABAs) on demand. Objective... 
BECLOMETHASONE | MAINTENANCE | RESPIRATORY SYSTEM | TOLERANCE | RELIEVER THERAPY | BUDESONIDE | METHACHOLINE | INDUCED BRONCHOSPASM | BETA-AGONISTS | CHILDREN | SALMETEROL | Bronchodilator Agents - therapeutic use | Terbutaline - adverse effects | Ethanolamines - adverse effects | Formoterol Fumarate | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Terbutaline - therapeutic use | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Asthma, Exercise-Induced - physiopathology | Humans | Male | Ethanolamines - administration & dosage | Vital Capacity - drug effects | Young Adult | Terbutaline - administration & dosage | Adrenergic beta-2 Receptor Agonists - adverse effects | Exercise Test - methods | Adrenergic beta-2 Receptor Agonists - therapeutic use | Adult | Female | Bronchodilator Agents - adverse effects | Drug Therapy, Combination | Glucocorticoids - adverse effects | Double-Blind Method | Drug Administration Schedule | Administration, Inhalation | Asthma, Exercise-Induced - prevention & control | Budesonide - adverse effects | Budesonide - therapeutic use | Adolescent | Adrenergic beta-2 Receptor Agonists - administration & dosage | Ethanolamines - therapeutic use | Budesonide - administration & dosage | Budesonide | Formoterol | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Asthma | Exercise | Fitness equipment | Steroids | 1506 | Clinical Medicine | Lungmedicin och allergi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Respiratory Medicine and Allergy
Journal Article
Malaria Journal, ISSN 1475-2875, 07/2017, Volume 16, Issue 1, pp. 269 - 9
Background: Ethiopia is among countries with a high malaria burden. There are several studies that assessed the efficacy of anti-malarial agents in the country... 
Plasmodium falciparum | Plasmodium vivax | Treatment | Malaria | Chloroquine | Efficacy | Adverse drug reactions | Safety | Ethiopia | Artemether-lumefantrine | INFECTIOUS DISEASES | WEST ETHIOPIA | SULFADOXINE-PYRIMETHAMINE | PLASMODIUM-FALCIPARUM MALARIA | TROPICAL MEDICINE | SOUTHERN ETHIOPIA | VIVAX MALARIA | THERAPEUTIC-EFFICACY | OPEN-LABEL TRIAL | JIMMA ZONE | PARASITOLOGY | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Malaria, Falciparum - drug therapy | Ethanolamines - adverse effects | Pyrimethamine - adverse effects | Humans | Fluorenes - therapeutic use | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Sulfadoxine - adverse effects | Chloroquine - adverse effects | Artemisinins - therapeutic use | Malaria, Vivax - drug therapy | Primaquine - therapeutic use | Sulfadoxine - therapeutic use | Treatment Failure | Ethanolamines - therapeutic use | Fluorenes - adverse effects | Primaquine - adverse effects | Artemisinins - adverse effects | Drug Combinations | Drug resistance | Patient outcomes | Analysis | Drugs | Vector-borne diseases | Human diseases | Sensitivity analysis | Countries | Erythrocytes | Agents | Clinical outcomes | Meta-analysis | Studies | Heterogeneity | Side effects | Quality | Organizations | Fatalities | Artemether | Software | Drug discovery | Public health
Journal Article
Thorax, ISSN 0040-6376, 04/2015, Volume 70, Issue 4, pp. 311 - 319
Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the... 
INDACATEROL | THERAPY | RESPIRATORY SYSTEM | DAILY SALMETEROL | DUAL BRONCHODILATION | LUNG-FUNCTION | DOUBLE-BLIND | EXACERBATIONS | OUTCOMES | GLYCOPYRRONIUM | HEALTH-STATUS | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Ethanolamines - administration & dosage | Indans - therapeutic use | Vital Capacity - drug effects | Quinolones - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Scopolamine Derivatives - administration & dosage | Adrenergic beta-2 Receptor Agonists - therapeutic use | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Scopolamine Derivatives - therapeutic use | Scopolamine Derivatives - adverse effects | Tiotropium Bromide | Glycopyrrolate - adverse effects | Double-Blind Method | Drug Administration Schedule | Glycopyrrolate - therapeutic use | Treatment Outcome | Glycopyrrolate - analogs & derivatives | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Quality of Life | Adrenergic beta-2 Receptor Agonists - administration & dosage | Ethanolamines - therapeutic use | Aged | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Care and treatment | Analysis | Formoterol | Indacaterol | Dosage and administration | Diagnosis | Quality of life | 1506 | Chronic Obstructive Pulmonary Disease | COPD Pharmacology
Journal Article